Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infants-Reference-Cited by-同舟云学术

Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infants

Published:2023-05 Issue:19 Volume:41 Page:3019-3023
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Goldblatt David^ORCID,Andrews Nick J.,Sheppard Carmen L.,Rose Samuel,Aley Parvinder K.,Roalfe Lucy,Southern Jo,Robinson Hannah,Pearce Emma,Plested Emma,Johnson Marina,Litt David J.,Fry Norman K.,Waight Pauline,Snape Matthew D.,Miller Elizabeth

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference15 articles.

1. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine;Whitney;NEnglJMed,2003

2. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study;Whitney;Lancet,2006

3. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study;Ladhani;Lancet Infect Dis,2018

4. The Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Indirect Immunity in High-Income Countries;Flasche;PLoS Med,2015

5. Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial;Goldblatt;Lancet Infect Dis,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The latest news in France before distribution of third-generation pneumococcal conjugate vaccines;Infectious Diseases Now;2024-08

2. Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study;The Lancet Infectious Diseases;2024-05

3. Phase 3 Safety and Immunogenicity Study of a Three-dose Series of Twenty-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers;Pediatric Infectious Disease Journal;2024-03-08